BBGBloomberg·4dBusiness
score+0.50
Swiss Respiratory Biotech Windward Up 7.9% in US Trading Debut
Original
Swiss Respiratory Biotech Windward Up 7.9% in US Trading Debut
“Positive market performance and successful capital raise are framed as constructive milestones for the company's growth.”